
JW Asset Management
Description
JW Asset Management is a prominent New York-based investment firm founded by Jason Wild, known for its deep specialization in the healthcare sector, with a particular emphasis on the rapidly evolving cannabis industry. The firm operates as a multi-strategy asset manager, deploying capital across both public and private markets. This dual approach allows JW Asset Management to engage with companies at various stages of their lifecycle, from growth-stage private enterprises to established public entities, leveraging its extensive industry knowledge and network.
The firm's investment philosophy is characterized by a long-term perspective and a hands-on approach, often taking significant stakes in its portfolio companies. Jason Wild, a former pharmacist, brings a unique blend of clinical understanding and financial acumen to the investment process, which has been instrumental in identifying and nurturing promising ventures within complex and regulated markets like cannabis. Their focus extends beyond just capital infusion; they often provide strategic guidance and operational support to help companies scale and navigate regulatory landscapes.
JW Asset Management manages a substantial portfolio, with assets under management (AUM) exceeding $2 billion as of recent reports, underscoring its significant financial capacity. While the firm engages in a range of investment sizes, for its private equity and growth equity investments, it typically acts as a lead or significant participant. For instance, the firm notably led a $100 million financing round for TerrAscend in 2020, demonstrating its capability to deploy substantial capital into high-growth opportunities.
The firm's strategic positioning within the healthcare and cannabis sectors, combined with its substantial capital base and experienced leadership, makes it a key player for companies seeking significant growth funding and strategic partnership. JW Asset Management's track record highlights its ability to identify and invest in companies poised for substantial market impact, particularly within its specialized domains.
Investor Profile
JW Asset Management has backed more than 22 startups, with 0 new investments in the last 12 months alone. The firm has led 13 rounds, about 59% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Pharmaceutical, Cannabis, Medical.
- Typical check size: $10M – $100M.
Stage Focus
- Series A (32%)
- Series B (18%)
- Series C (14%)
- Post Ipo Equity (14%)
- Series Unknown (9%)
- Seed (9%)
- Debt Financing (5%)
Country Focus
- United States (91%)
- Canada (9%)
Industry Focus
- Pharmaceutical
- Cannabis
- Medical
- Biotechnology
- Advertising
- Cloud Computing
- Cloud Data Services
- Compliance
- Enterprise Software
- Marketing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.